![Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial]()
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trialRomeo, Clémence; Joly, Florence; Ray-Coquard, Isabelle; El Kouri, Claude; Mercier-Blas, Anne; Berton-Rigaud, Dominique; Kalbacher, Elsa; Cojocarasu, Oana; Fabbro, Michel; Cretin, Jacques; Zannetti, Alain; Abadie-Lacourtoisie, Sophie; Mollon, Delphine; Hardy-Bessard, Anne-Claire; Provansal, Magali; Blot, Emmanuel; Delbaldo, Catherine; Lesoin, Anne; Freyer, Gilles; You, Benoît · Gynecologic Oncology · 2018